Trial Identifier: | D3250R00043 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05091333 |
Start Date: | March 2022 |
Primary Completion Date: | January 2025 |
Study Completion Date: | January 2025 |
Condition: | Asthma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.